A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity
NCT03893591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82
Last updated 2020-04-01
Summary
A prospective cohort study to determine whether a high body weight (BMI equal to or greater than 35 kg / m 2) has an effect on anticoagulant Apixaban level in the blood of patients with atrial fibrillation.
Conditions
- Anticoagulant
- Apixaban
- Obesity
Interventions
- DIAGNOSTIC_TEST
-
Anti Xa levels
one Blood sample
Sponsors & Collaborators
-
HaEmek Medical Center, Israel
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-06
- Primary Completion
- 2020-02-29
- Completion
- 2020-02-29
Countries
- Israel
Study Locations
More Related Trials
-
Biomarkers in Patients Undergoing Atrial Fibrillation Ablation
NCT03388333 ·Status: COMPLETED
-
LAAO Versus NOAC in Patients with AF and PCI
NCT05353140 ·Status: RECRUITING ·Phase: NA
-
Apixaban in Atrial Fibrillation Registry
NCT02563639 ·Status: COMPLETED
-
Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf)
NCT03441633 ·Status: COMPLETED
-
Atrial Fibrillation in Relationship to Plasma Biomarkers
NCT04710745 ·Status: UNKNOWN
-
Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants
NCT03181386 ·Status: COMPLETED ·Phase: PHASE3
-
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
NCT02608099 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Adipokines In Atrial Fibrillation
NCT03592732 ·Status: UNKNOWN
-
Atrial Fibrillation Incidence, Risk Factors and Genetics
NCT00021905 ·Status: COMPLETED
-
IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation
NCT03259373 ·Status: COMPLETED ·Phase: NA
-
Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County
NCT04233515 ·Status: COMPLETED
-
First-line Treatment for Atrial Fibrillation in Cardiology and Geriatric Departments
NCT02884661 ·Status: COMPLETED
-
Understanding and Improving Anticoagulation Dosing for Patients With Atrial Fibrillation
NCT03719144 ·Status: COMPLETED
-
Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation
NCT03002740 ·Status: WITHDRAWN
-
Relationship Between Apelin and New-onset Atrial Fibrillation After Coronary Artery Bypass Grafting
NCT02807532 ·Status: COMPLETED
-
Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF
NCT03061123 ·Status: COMPLETED
-
The Thrombotic Potential of Heart Chambers in the Presence or Absence of Atrial Fibrillation.
NCT03795883 ·Status: COMPLETED
-
Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
NCT06954610 ·Status: RECRUITING
-
Intention to Prescribe/Take OAC Depending on the Number of Risk Diagrams , and Period for the Estimation of the Risk.
NCT02746107 ·Status: COMPLETED ·Phase: NA
-
An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting
NCT05471830 ·Status: COMPLETED
-
Multidisciplinary Team Approach to Prescribe Antithrombotic Therapy in Older People With Atrial Fibrillation
NCT04932603 ·Status: COMPLETED
-
Feasibility Testing of the Alert for Atrial Fibrillation Program
NCT01988974 ·Status: COMPLETED ·Phase: NA
-
Heparin Requirements in Patients Undergoing Atrial Fibrillation Ablation on Coumadin vs NOACs
NCT03520868 ·Status: COMPLETED
-
Study on Left Atrial Function of Atrial Fibrillation After Radiofrequency Ablation With Statin Therapy
NCT02776956 ·Status: COMPLETED ·Phase: NA
-
Oral Anticoagulation Therapy Pilot Study
NCT01959425 ·Status: TERMINATED ·Phase: PHASE4